Cargando…

hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide

The aim of this study was to investigate the effect of a eukaryotic expression vector expressing hsa-miR-203 on the sensitivity of K562 leukemia cells to arsenic trioxide (ATO) and the possible mechanism of action. The eukaryotic expression vector expressing the hsa-miR-203 plasmid (PmiR-203) was tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	HE, JIN-HUA, LI, YU-MIN, LI, YU-GUANG, XIE, XING-YI, WANG, LI, CHUN, SHUN-YI, CHENG, WU-JIA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671790/ https://www.ncbi.nlm.nih.gov/pubmed/23737871 http://dx.doi.org/10.3892/etm.2013.981

Ejemplares similares

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
por: Chim, Chor Sang, et al.
Publicado: (2011)

miR-203 Inhibits Alcohol-Induced Hepatic Steatosis by Targeting Lipin1
por: Cheng, Xiao-Yu, et al.
Publicado: (2018)

miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1
por: Zhang, Yi, et al.
Publicado: (2016)

hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms
por: Chang, XiaoYan, et al.
Publicado: (2017)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate
por: Li, Yajuan, et al.
Publicado: (2013)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021)

hsa_circ_0072389, hsa_circ_0072386, hsa_circ_0008621, hsa_circ_0072387, and hsa_circ_0072391 aggravate glioma via miR-338-5p/IKBIP
por: Liang, Jian, et al.
Publicado: (2021)

Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia
por: Jia, Yan, et al.
Publicado: (2020)

Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
por: Chau, David, et al.
Publicado: (2015)

Arsenic trioxide-mediated suppression of miR-182-5p is associated with potent anti-oxidant effects through up-regulation of SESN2
por: Lin, Liang-Ting, et al.
Publicado: (2018)

MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells()
por: Aakko, Sofia, et al.
Publicado: (2018)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
por: Masciarelli, S, et al.
Publicado: (2018)

MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide
por: Wang, Zhiguo, et al.
Publicado: (2019)

The miR-203a Regulatory Network Affects the Proliferation of Chronic Myeloid Leukemia K562 Cells
por: He, Jinhua, et al.
Publicado: (2021)

Antileukemic Activity of hsa-miR-203a-5p by Limiting Glutathione Metabolism in Imatinib-Resistant K562 Cells
por: Singh, Priyanka, et al.
Publicado: (2022)

miR-203, fine-tunning neuroinflammation by juggling different components of NF‐κB signaling
por: Li, Shufang, et al.
Publicado: (2022)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017)

Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia
por: Rossi, Maura, et al.
Publicado: (2013)

Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2015)

miR-203 drives breast cancer cell differentiation
por: Martínez-Illescas, Nuria G., et al.
Publicado: (2023)

miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells
por: Gu, Shiyan, et al.
Publicado: (2017)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

“Seed-Milarity” Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity
por: Bertero, Thomas, et al.
Publicado: (2012)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia
por: Navarro, A, et al.
Publicado: (2016)

Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression
por: Wu, Xuerui, et al.
Publicado: (2022)

miR-203 inhibits the traumatic heterotopic ossification by targeting Runx2
por: Tu, Bing, et al.
Publicado: (2016)

miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC
por: Wang, Nan, et al.
Publicado: (2014)

MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)
por: Petty, Robert D., et al.
Publicado: (2016)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
por: Tesolato, Sofía Elena, et al.
Publicado: (2023)

Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development
por: Hao, Qiang, et al.
Publicado: (2013)

Arsenic Trioxide and Resveratrol Show Synergistic Anti-Leukemia Activity and Neutralized Cardiotoxicity
por: Fan, Yuhua, et al.
Publicado: (2014)

Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
por: Tao, Wenhua, et al.
Publicado: (2016)

MiR-302a sensitizes leukemia cells to etoposide by targeting Rad52
por: Liu, Xiaoning, et al.
Publicado: (2017)

Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer
por: Ji, Hui, et al.
Publicado: (2014)

Identification of miR-203a, mir-10a, and miR-194 as predictors for risk of lymphovascular invasion in head and neck cancers
por: Karmakar, Moumita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ntsncfaiq2ab29qgdqu72bgl0d